Literature DB >> 20844477

Pharmacological enhancement of memory and executive functioning in laboratory animals.

Stan B Floresco1, James D Jentsch.   

Abstract

Investigating how different pharmacological compounds may enhance learning, memory, and higher-order cognitive functions in laboratory animals is the first critical step toward the development of cognitive enhancers that may be used to ameliorate impairments in these functions in patients suffering from neuropsychiatric disorders. Rather than focus on one aspect of cognition, or class of drug, in this review we provide a broad overview of how distinct classes of pharmacological compounds may enhance different types of memory and executive functioning, particularly those mediated by the prefrontal cortex. These include recognition memory, attention, working memory, and different components of behavioral flexibility. A key emphasis is placed on comparing and contrasting the effects of certain drugs on different cognitive and mnemonic functions, highlighting methodological issues associated with this type of research, tasks used to investigate these functions, and avenues for future research. Viewed collectively, studies of the neuropharmacological basis of cognition in rodents and non-human primates have identified targets that will hopefully open new avenues for the treatment of cognitive disabilities in persons affected by mental disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20844477      PMCID: PMC3055518          DOI: 10.1038/npp.2010.158

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  328 in total

1.  Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex.

Authors:  Yogita Chudasama; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2004-09       Impact factor: 7.853

Review 2.  Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Authors:  Amy F T Arnsten; Bao-Ming Li
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

3.  Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys.

Authors:  Alvin V Terry; Jerry J Buccafusco; Gerd D Bartoszyk
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

Review 4.  Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties.

Authors:  Karin R Tietje; David J Anderson; R Scott Bitner; Eric A Blomme; Paul J Brackemeyer; Clark A Briggs; Kaitlin E Browman; Dagmar Bury; Peter Curzon; Karla U Drescher; Jennifer M Frost; Ryan M Fryer; Gerard B Fox; Jens Halvard Gronlien; Monika Håkerud; Earl J Gubbins; Sabine Halm; Richard Harris; Rosalind J Helfrich; Kathy L Kohlhaas; Devalina Law; John Malysz; Kennan C Marsh; Ruth L Martin; Michael D Meyer; Angela L Molesky; Arthur L Nikkel; Stephani Otte; Liping Pan; Pamela S Puttfarcken; Richard J Radek; Holly M Robb; Eva Spies; Kirsten Thorin-Hagene; Jeffrey F Waring; Hilde Ween; Hongyu Xu; Murali Gopalakrishnan; William H Bunnelle
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

5.  The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.

Authors:  M Carli; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  2000-04       Impact factor: 4.530

6.  Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.

Authors:  Paul J Fletcher; Catherine C Tenn; Zoë Rizos; Vedran Lovic; Shitij Kapur
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

Review 7.  Molecular mechanisms of stress-induced prefrontal cortical impairment: implications for mental illness.

Authors:  Avis B Hains; Amy F T Arnsten
Journal:  Learn Mem       Date:  2008-08-06       Impact factor: 2.460

8.  Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms.

Authors:  Nagi Idris; Jo Neill; Ben Grayson; Benny Bang-Andersen; Louise M Witten; Lise Tøttrup Brennum; Jørn Arnt
Journal:  Psychopharmacology (Berl)       Date:  2009-10-23       Impact factor: 4.530

Review 9.  Experimental pharmacology of Alzheimer disease.

Authors:  B S Greenwald; K L Davis
Journal:  Adv Neurol       Date:  1983

10.  L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease.

Authors:  Roshan Cools; Simon J G Lewis; Luke Clark; Roger A Barker; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2006-07-12       Impact factor: 7.853

View more
  47 in total

1.  Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning.

Authors:  Gemma L Dalton; Liya M Ma; Anthony G Phillips; Stan B Floresco
Journal:  Psychopharmacology (Berl)       Date:  2011-03-08       Impact factor: 4.530

Review 2.  Memory enhancement: consolidation, reconsolidation and insulin-like growth factor 2.

Authors:  Cristina M Alberini; Dillon Y Chen
Journal:  Trends Neurosci       Date:  2012-02-14       Impact factor: 13.837

3.  Tet1 is critical for neuronal activity-regulated gene expression and memory extinction.

Authors:  Andrii Rudenko; Meelad M Dawlaty; Jinsoo Seo; Albert W Cheng; Jia Meng; Thuc Le; Kym F Faull; Rudolf Jaenisch; Li-Huei Tsai
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

4.  Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice.

Authors:  Adam B Steinmetz; Sarah A Stern; Amy S Kohtz; Giannina Descalzi; Cristina M Alberini
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

5.  Persistent cognitive and morphological alterations induced by repeated exposure of adolescent rats to the abused inhalant toluene.

Authors:  K M Braunscheidel; J T Gass; P J Mulholland; S B Floresco; J J Woodward
Journal:  Neurobiol Learn Mem       Date:  2017-07-15       Impact factor: 2.877

Review 6.  Dissecting impulsivity and its relationships to drug addictions.

Authors:  J David Jentsch; James R Ashenhurst; M Catalina Cervantes; Stephanie M Groman; Alexander S James; Zachary T Pennington
Journal:  Ann N Y Acad Sci       Date:  2014-03-21       Impact factor: 5.691

7.  Improvement of attention with amphetamine in low- and high-performing rats.

Authors:  Karly M Turner; Thomas H J Burne
Journal:  Psychopharmacology (Berl)       Date:  2016-07-28       Impact factor: 4.530

Review 8.  Mechanisms of memory enhancement.

Authors:  Sarah A Stern; Cristina M Alberini
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-11-13

9.  Simultaneous blockade of dopamine and noradrenaline reuptake promotes disadvantageous decision making in a rat gambling task.

Authors:  Petra J J Baarendse; Catharine A Winstanley; Louk J M J Vanderschuren
Journal:  Psychopharmacology (Berl)       Date:  2012-09-12       Impact factor: 4.530

10.  NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test.

Authors:  Karolina J Janczura; Rafal T Olszewski; Tomasz Bzdega; Dean J Bacich; Warren D Heston; Joseph H Neale
Journal:  Eur J Pharmacol       Date:  2012-11-29       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.